MRNA
Moderna
$55.63
+$1.56 (+2.89%)Jul 27, 2026
Key metrics
The numbers that frame MRNA today
- Market cap
- $22.07B
- P/E (TTM)
- -6.9
- EV / FCF
- -13.4
- Gross margin
- 22.1%
- EV / Sales
- 9.6
- ROIC
- -33.6%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $22.28
- 52wk High
- $85.60
Growth
Revenue and earnings trend for MRNA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MRNA
Is Moderna a good buy?
Hold. Moderna has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Moderna is selling at a very high price.
What is the market capitalization of MRNA?
Moderna's market capitalization is $22.07B.
What is the P/E ratio for MRNA stock?
Moderna's current P/E ratio is -6.9.
What is the 52-week high for MRNA stock?
The 52-week high for Moderna is $85.60. The current close of $55.63 is 35% below that high.
What is the 52-week low for MRNA stock?
The 52-week low for Moderna is $22.28. The current close of $55.63 is 149.7% above that low.
Does MRNA stock pay dividends?
Moderna does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MRNA?
Moderna's Debt / Equity ratio is 0.17.